To investigate the effects of respiration defects on the disease phenotypes, we generated trans-mitochondrial mice (mito-mice) by introducing a mutated G13997A mtDNA, which specifically induces respiratory complex I defects and metastatic potentials in mouse tumor cells. First, we obtained ES cells and chimeric mice containing the G13997A mtDNA, and then we generated mito-mice carrying the G13997A mtDNA via its female germ line transmission. The three-month-old mito-mice showed complex I defects and lactate overproduction, but showed no other phenotypes related to mitochondrial diseases or tumor formation, suggesting that aging or additional nuclear abnormalities are required for expression of other phenotypes.
Introduction
Pathogenic mtDNA mutations that induce significant respiration defects are responsible for expression of mitochondrial diseases [1] [2] [3] . Moreover, such respiration defects and the resultant over production of reactive oxygen species (ROS) and lactate could also be involved in aging, age-associated disorders, and tumor development [2] [3] [4] [5] . However, because of the control of the mitochondrial respiratory function by both nuclear DNA and mtDNA [1, 2] , it has been difficult to determine which genome, nuclear DNA or mtDNA, is responsible for the respiration defects and the resultant abnormalities.
Our previous study [6] resolved this issue by using complete mtDNA exchange technology between two mouse lung carcinoma cell lines, P29 and A11, which express different metastatic phenotypes. The results showed that the highly metastatic A11 cells possess a somatic mtDNA mutation G13997A in the ND6 gene that encodes NADH dehydrogenase subunit 6, one of the subunits of respiration complex I, and that the mutation reversibly controls development of metastases in tumor cells. Moreover, the induction of metastasis in the tumor cells was due to the complex I defectsmediated overproduction of ROS, but not to the complex I defectsmediated overproduction of lactate [7] . In humans, complex I defects caused by pathogenic mtDNA mutations are also thought to be responsible for expression of Leber's hereditary optic neuropathy (LHON), one of the most frequent mitochondrial diseases [1] [2] [3] .
Therefore, generation of trans-mitochondrial mito-mice possessing the G13997A mtDNA introduced from highly metastatic tumor cells would provide an ideal system to examine whether somatic mtDNA mutations introduced from highly metastatic tumor cells into ES cells can be transmitted to the following generations, and whether they can induce complex I defects in living mouse tissues and induce phenotypes related to LHON, aging, and metastasis. Here, we generated the trans-mitochondrial mito-mice with homoplasmic G13997A mtDNA in all the tissues using mtDNA transfer technology, and then examined the resultant phenotypes.
Materials and methods

Cell lines and cell culture
Mouse tumor cells were grown in RPMI 1640 (Nissui Seiyaku, Tokyo, Japan) containing 10% fetal calf serum, uridine (50 ng/ml), 
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The host ES cells were pretreated with rhodamine 6G (R6G; 0.38-1.5 lg/ml in 3% ethanol) for 48 h in medium supplemented with uridine (50 ng/ml) and pyruvate (0.1 lg/ml) to eliminate endogenous mitochondria and mtDNA [9, 10] . The ES cells were then washed with phosphate-buffered saline (PBS) and suspended in R6G-free medium for 2 h to allow recover. The mtDNA donor B82mtA11 cells pretreated with cytochalasin B (10 lg/ml) for 10 min were centrifuged at 15 000Âg for 30 min at 37°C for enucleation. The resultant cytoplasts were fused with R6G-pretreated ES cells using polyethylene glycol, and the fusion mixture was cultivated in selective medium with HAT (hypoxanthine aminopterin thymidine). Seven days after fusion, growing colonies were picked up for further examination.
Generation of founder chimeric mice and mito-mice13997
After frozen 8-cell-stage embryos of ICR strain mice (ARK Resource Co., Ltd., Kumamoto, Japan) were thawed, their zona pellucidae were removed by treatment with acidified Tyrode's buffer (Sigma-Aldrich). Each treated embryo was placed with 10 ESmt13997 cells in an indentation well of a 35-mm culture dish and cultured overnight to enable aggregation. The next day, the embryos were transferred into pseudopregnant ICR females (Japan SLC). The resultant progeny were identified by their coat-color chimerism. Founder (F 0 ) chimeric females were mated with C57BL/6 J (B6; CLEA Japan) males to produce the F 1 generation, and the F 1 female mice were backcrossed with B6 males. The F 3 generation was used for further analyses.
Genotyping of mtDNAs
To detect the presence of the G13997A mutation, a 147-bp fragment containing the 13997 site was amplified by PCR. The nucleotide sequences from nucleotide position 13963 to 13996 (5 0 -CCCACTAACAATTAAACCTAAACCTCCATActTA-3 0 , small letters indicate the mismatch site) and nucleotide position 14109 to 14076 (5 0 -TTCATGTCATTGGTCGCAGTTGAATGCTGTGTAG-3 0 ) were used as oligonucleotide primers. Combination of the PCR-generated mutation with the G13997A mutation creates a restriction site for Afl II, and generates 114-bp and 33-bp fragments on Afl II digestion. The restriction fragments were separated by electrophoresis in a 3% agarose gel. For quantification of the G13997A mtDNA, we used the NIH IMAGE program.
Analysis of multipotency of mtDNA-repopulated ES cells
To test the multipotency of the mtDNA-repopulated ES cells, ES cells and ESmt13997 cells, 1 Â 10 6 cells of each, were inoculated subcutaneously into the backs of 6-week-old nude mice (JCL, BALB/c-nu/ nu; CLEA Japan). The resulting teratomas (tumors) were fixed in 30% neutral-buffered formalin, embedded in paraffin, stained with hematoxylin and eosin (HE) and examined histologically.
Biochemical measurement of respiratory enzyme activities
Mitochondrial respiratory complex I (NADH dehydrogenase), complex II (succinate dehydrogenase), complex III (cytochrome c reductase), and complex IV (cytochrome c oxidase) are components of the electron-transport chain, and are located in the mitochondrial inner membrane. The activity of these enzymes was assayed as described previously [11] . Briefly, for the estimation of complex I + III activity, NADH and cytochrome c (oxidized form) were used as substrates and the reduction of cytochrome c was monitored by measuring absorbance at 550 nm. For the estimation of complexes II + III activity, sodium succinate and cytochrome c (oxidized form) were used as substrates, and the reduction of cytochrome c was monitored as described above. For the estimation of complex IV activity, cytochrome c (reduced form) was used as a substrate, and the oxidation of cytochrome c was measured at 550 nm.
Lactate measurement
To determine fasting blood lactate concentrations, blood was collected from the tail veins of mice after overnight starvation. After oral administration of glucose (1.5 g/kg body weight), blood was again collected, and lactate concentrations were measured using an automatic blood lactate test meter (Lactate Pro, ARKRAY, Kyoto, Japan).
Measurement of ROS production
ROS generation was detected with 2 0 ,7 0 -dichlorofluorescin diacetate (DCFH-DA; Molecular Probe, Inc., Eugene, OR, USA). Cells were incubated with DCFH-DA, washed twice, and then immediately analyzed by using a FACScan flow cytometer (Becton Dickinson, Mountain View, CA, USA).
Western blot analysis of ROS scavenger enzymes
Tissue samples were lysed on ice in 2% SDS (Wako, Osaka, Japan), 50 mM Tris-HCl (pH 6.8), 10% Glycerol (Wako), 5% 2-Mercaptoethanol (Wako) and 0.02% Bromophenol Blue (Wako). After centrifugation at 45 000 rpm for 30 min at 4°C, the supernatant was used as a protein sample. For Western blot analysis of manganese superoxide dismutase (MnSOD), glutathione peroxidase (GPx), and catalase, the proteins were resolved by SDS-PAGE under reducing conditions. The resolved proteins were transferred electrophoretically to a nitrocellulose membrane (GE Healthcare Bio-Science KK, Tokyo, Japan). The membrane was incubated with either anti-MnSOD antibody (Upstate Biotechnology, Lake Placid, NY, USA), anti-Glutathione Peroxidase 1 antibody (Abcam, Cambridge, UK), or anti-Catalase antibody (Calbiochem, Darmstadt, Germany) for 2 h. Proteins were detected using Immunostaining HRP-1000 (Konica Minolta, Tokyo, Japan). An anti-b-actin antibody (Sigma-Aldrich) was used for the loading control.
Histological analysis of eyes
Eyes with attached optic nerves were fixed in 30% neutral-buffered formalin and embedded in paraffin. Cross-sections of the optic nerve and horizontal sections of the retina were stained with HE for light microscopic examination.
Results
Isolation of trans-mitochondrial ES cells carrying G13997A mtDNA
To obtain trans-mitochondrial ES cells carrying the G13997A mtDNA (ESmt13997 cells), we used mouse ES cells and mouse B82mtA11 cells as the recipients and the donors of the G13997A mtDNA, respectively (Supplementary Table 1 ). The B82mtA11 cells were isolated previously [6] by fusing enucleated A11 cells with mtDNA-less B82 cells. Since the B82mtA11 cells could not survive in the selection medium with HAT, they could be used as mtDNA donors for mouse ES cells (Supplementary Table 1) .
ES cells were pretreated with R6G to eliminate endogenous mitochondria and mtDNA, and then fused with enucleated B82mtA11 cells. Unfused R6G-pretreated ES cells failed to grow due to the absence of mitochondria and mtDNA, and unenucleated B82mtA11 cells failed to grow by the HAT selection (Supplementary Table 1 ).
Growing colonies in the selection medium were clonally isolated, and seven clones were used for mtDNA genotyping. All seven clones possessed various proportions of the imported G13997A mtDNA (Fig. 1A) . The mtDNA without the mutation in these clones would be derived from feeder cells or ES cells carrying their own mtDNA due to incomplete R6G pre-treatment. We selected two clones, ESmt13997-5 and -7, which possessed 55% and 85% G13997A mtDNA, respectively, as ESmt13997 cells for use in further experiments.
Effects of the imported G13997A mtDNA on differentiation of the ESmt13997 cells
In previous reports [12] [13] [14] , chimeric mice were not obtained from trans-mitochondrial ES cells carrying the pathogenic mtDNAs that induce significant respiration defects, suggesting that significant respiration defects inhibited the differentiation of multipotent ES cells. Therefore, we tested whether the ESmt13997 cells are able to differentiate into various tissues, by subcutaneously inoculating ESmt13997-7 cells into the back skin of nude mice. They formed primary tumors, which grew faster than those of the ES cells with wild-type mtDNA (Supplementary Fig. 1A ). Faster growth of the inoculated ESmt13997 cells would be due to the induction of hypoxia-resistant phenotypes in the cells with the G13997A mtDNA [6] . Fig. 1 . The mtDNA genotyping of ESmt13997 and mito-mice13997. Genotyping of mtDNA from (A) ESmt13997 clones, (B) F 1 male tissues, and (C) F 3 male tissues. PCR products were digested with Afl II. The G13997A mtDNA produced 114-and 33-bp fragments due to the gain of an Afl II site by the G13997A substitution in the ND6 gene, whereas wild-type mtDNA without the mutation produced a 147-bp fragment. B82mtA11 cells with homoplasmic G13997A mtDNA were used as positive controls, and ES cells and B82mtB6 cells with wild-type mtDNA were used as negative controls. Br, brain; He, heart; Li, liver; Ki, kidney; Sk, skeletal muscle; Te, testis. Two were females and five were males. We used these two F 1 females for breeding, and obtained F 2 mito-mice13997. All F 2 mito-mice13997 possessed homoplasmic G13997A mtDNA in their tails. The number of F 3 pups and their body weight were comparable to those of B6 mice.
secretory cells, bone cells, striated muscle, and hair follicles (Supplementary Fig. 1B) , even though ESmt13997-7 cells showed faster growth as primary tumors ( Supplementary Fig. 1A ). These observations suggested that the ESmt13997 cells could be used to obtain F 0 chimeric mice.
Generation of mito-mice13997 carrying homoplasmic G13997A mtDNA
To generate F 0 chimeric mice, ESmt13997-5 and -7 cells were aggregated with 8-cell-stage embryos of ICR strain mice. We obtained 24 F 0 chimeric mice (11 females and 13 males) showing 5-90% chimerism by coat color ( Table 1) . The results of mtDNA genotyping showed that 5 of 13 F 0 males and 6 of 11 F 0 females possessed 1-43% G13997A mtDNA in their tails (Table 1) . Because mouse mtDNA inherits strictly maternally [15, 16] , we used all 11 F 0 females as founders, irrespective of whether their tails possessed the G13997A mtDNA or not, and mated them with B6 males for examination of its female germ line transmission to the F 1 progeny.
Of the 11 F 0 females, only one produced F 1 pups (2 females and 5 males) that possessed homoplasmic G13997A mtDNA in their tails (Table 1 ). This F 0 female was derived from the ES mt13997-5 clone carrying 55% G13997A mtDNA. Probably, the ESmt13997-5 possessed homoplasmic G13997A mtDNA, and estimation of 55% G13997A mtDNA in the clone sample (Fig. 1A) was due to the presence of feeder cells.
Then, we examined one of the F 1 males with homoplasmic G13997A mtDNA in its tail, and showed that all tissues tested possessed homoplasmic G13997A mtDNA (Fig. 1B) . This finding suggests that the G13997A mtDNA transmitted maternally from an F 0 female to F 1 progeny, and that the F 1 mice carry the G13997A mtDNA originally derived from highly metastatic Lewis lung carcinoma A11 cells. Mice carrying the homoplasmic G13997A mtDNA in all tissues were named mito-mice13997.
Our previous reports [12, 17] showed that mito-mice generated by introduction of the mtDNA with a large-scale deletion (DmtDNA) into fertilized eggs did not possess homoplasmic DmtDNA, because the DmtDNA induced embryonic lethality. Thus, generation of the F 1 mice carrying homoplasmic G13997A mtDNA (Fig. 1B) indicates that the pathogenicity of the G13997A mtDNA was not sufficient to induce embryonic lethality. We mated two F 1 female mito-mice13997 with B6 males and obtained F 2 progeny. Then, we obtained F 3 progeny from seven F 2 females. Three-month-old male mito-mice13997 of the F 3 generation were used for further examination of respiratory function and disease phenotypes, while female mito-mice13997 were used to breed and maintain the mito-mice13997 line. Genotyping of mtDNA in one of the F 3 males confirmed homoplasmic G13997A mtDNA in all the tissues tested (Fig. 1C) .
Mitochondrial dysfunction and disease phenotypes in the mitomice13997
Using the mito-mice13997 (three-month-old F 3 males), first we analyzed respiratory complex activities in various tissues. Tissues from age-matched B6 mice were used as normal controls. The activity levels of complexes II + III and complex IV in the tissues of mito-mice13997 were not significantly different to normal levels ( Fig. 2A) . In contrast, all mito-mice13997 tissues tested showed significantly less complex I + III activity (about 70% normal level). Since the activity of complexes II + III was normal in the mitomice13997 tissues, we consider that the reduced activity of complexes I + III reflects complex I activity alone.
Our previous study [6] showed that complex I defects caused by the G13997A mtDNA induced simultaneous overproduction of ROS and lactate in cultivated tumor cells. So, we estimated the amounts of ROS in the liver cells and splenocytes of the mito-mice13997 by means of fluorescence-activated cell sorting (FACS; Fig. 2B ). The results showed no significant increase in the amount of ROS in the mito-mice13997 tissues compared to the control B6 mice. Moreover, the levels of anti-oxidant enzymes, such as MnSOD, GPx, and catalase in the liver cells and splenocytes of the mitomice13997 were not significantly different to those in the control B6 mice (Fig. 2C) . Thus, the tissues in living mice may have some systems other than the enhanced expression of anti-oxidant enzymes that suppress the ROS overproduction caused by the mutated mtDNA.
In contrast, after glucose loading, the lactate level in blood was significantly higher in mito-mice13997 than in control B6 mice (Fig. 3A) . This phenotype is also found in other mito-mice [13, 17] . Moreover, in human cases, lactic acidosis is one of the most common phenotypes in the patients with mitochondrial diseases [1] [2] [3] , and our results suggest that the mito-mice13997 can be used as models of lactic acidosis.
In humans, complex I defects caused by mtDNA mutations are also associated with LHON [1] [2] [3] . The typical clinical features of LHON are loss of central vision and optic nerve atrophy in young males due to the selective loss of retinal ganglion cells, which histologically correspond to the loss of the optic nerve and the loss of both the nerve fiber layer and ganglion cell layer in the retina [18] . So, we histologically examined the retinal ganglion cells in threemonth-old male mito-mice13997. The results showed normal optic nerve in the size and nerve fiber density (Fig. 3B upper panels) , and normal histology in both the nerve fiber layer and ganglion cell layer in the retina (Fig. 3B lower panels) . These histological observations indicated that the male mito-mice13997 did not express the typical phenotypes of LHON [18] at least 3 months after birth.
Finally we examined the tendency to form tumors using threemonth-old mito-mice13997 of F 3 generation, since their G13997A mtDNA was derived from highly metastatic Lewis lung carcinoma A11 cells, and they showed high lactate levels in the blood (Fig. 3A) . However, all six mito-mice13997 tested showed no bias towards the preferential formation of tumors. These results can be explained by the fact that the G13997A mtDNA induces metastasis in tumor cells, but does not induce tumor development in normal cells [6] .
Discussion
Because mouse G13997A mtDNA in highly metastatic tumor cells induces respiratory complex I defects and leads to overproduction of ROS and lactates [6, 7] , we expected that the generation of the mito-mice13997 with homoplasmic G13997A mtDNA would be an effective means to examine the conventional mitochondrial theories [2] [3] [4] [5] proposing that ROS and lactate overproduction caused by pathogenic mtDNA mutations is responsible for aging, age-associated disorders, and tumor development.
As expected, the mito-mice13997 showed complex I defects ( Fig. 2A) and resultant overproduction of lactate (Fig. 3A) . How- OPL, outer plexiform layer; ONL, outer nuclear layer. Bar, 100 lm (upper panels); Bar, 10 lm (lower panels).
ever, the deficiency in complex I activity was less in mitomice13997 tissues than in the mtDNA donor B82mtA11 cells ( Fig. 2A) . A similar compensatory effect was observed, when mito-mice6589 tissues expressing complex IV defects due to homoplasmic T6589C mtDNA mutation in the COI gene were compared to their mtDNA donor cells [13] . Thus, the tissues in living mice may have some activities that compensate for the reduced respiration defects caused by pathogenic mtDNA mutations. In addition, ROS overproduction, LHON phenotypes, and tumor formation were not observed in the mito-mice13997. Probably, the tissues in living mice are capable not only of compensating for reduced complex I activity, but also of suppressing ROS overproduction. In this study we used young mito-mice13997 to examine these phenotypes. Thus, we cannot at present exclude the possibility that aging of mito-mice13997 abolishes the compensatory function in the young tissues, resulting in expression of these phenotypes in aged mito-mice13997.
With respect to the LHON phenotypes, it has been proposed that a mutation in either the ND1, ND4, or ND6 gene of mtDNA is necessary, but not sufficient to express LHON phenotypes, and that some additional nuclear gene mutations are required [1] [2] [3] . Hence, addition of similar nuclear gene mutations may induce the LHON phenotypes in the mito-mice13997. The absence of tumor formation in the mito-mice13997 suggests that increased lactate levels in the presence of oxygen, which is known as the Warburg effect [19] , were not sufficient to induce tumor formation in the mitomice13997. Since our previous report [6] showed that the G13997A mtDNA induces metastasis in tumor cells, but does not induce tumor formation in normal cells, it can be expected that the mito-mice13997 would not show tumor formation, but would show high metastasis, only when nuclear gene mutations or a different nuclear background that preferentially induce tumor formation were introduced.
Therefore, aging of the mito-mice13997 and/or the introduction of different nuclear backgrounds or nuclear gene abnormalities into the mito-mice13997 would be important for further investigation of the capability of the mito-mice13997 to express significant complex I defects, ROS overproduction, tumor formation, metastasis, and the phenotypes related to LHON and aging.
